Navigation Links
Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
Date:11/7/2012

CARLSBAD, Calif., Nov. 07, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at 2:00 p.m. ET in New York, NY. 

A live audio webcast of the presentation and panel will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay will be available on the Isis Web site within 48 hours and will be archived for a limited time.

About Isis Pharmaceuticals, Inc.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, in the United States and Europe following regulatory approval.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

Forward-Looking Statements
This press release includes forward-looking statements regarding Isis' business and the therapeutic potential of Isis' technologies and products in development.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2012 Results
2. Radiopharmaceuticals and Contrast Media: Frost & Sullivan Predicts Market Growth in Europe
3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Third Quarter 2012 Financial Results
4. Enanta Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
5. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
6. AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Thom Rowland Joins Arbor Pharmaceuticals as Vice President of Commercial Operations
8. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
9. Jazz Pharmaceuticals Announces Support for National Campaign Designed to Curb Prescription Drug Abuse
10. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
11. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 Baebies, Inc. today announced the completion ... The oversubscribed round of financing included key investors Rex ... Cunning Capital, Triad, LLC, the Duke Angel Network and ... of Advanced Liquid Logic,s (ALL) former investors including Charleston ... "Rex is pleased to support this promising ...
(Date:7/28/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical ... autoimmune diseases, asthma and allergic diseases, and cancer, announced ... after the market closes on Tuesday, August 4, 2015. ... the same day at 4:30 p.m. ET (1:30 p.m. ... corporate update. The live call may be ...
(Date:7/28/2015)... Oncology, Inc. (OTC: CSBR), engaged in the development of ... and use of oncology drugs, today announced its financial ... Fourth Quarter and Recent Business Highlights: , ... period result , Procured a quarterly record high ... Champions Oncology CEO, stated, "The end of fiscal 2015 ...
Breaking Medicine Technology:Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 3Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 4Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 5Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 6Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 7Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 8Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 9Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 10Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 11
... MISSISSAUGA, Ontario, Aug. 23, 2011 Valeant Pharmaceuticals International, ... has filed a Notice of Intention to make a ... (the "TSX") and that the TSX has accepted the ... have the right to purchase for cancellation, commencing August ...
... BOSTON, Aug. 23, 2011 Solos Endoscopy, Inc. (OTCPK: SNDY) ... will result in the reduction of more than $620,000 in ... settlement agreement and new consulting agreement will result in a ... Solos Endoscopy posted its financial statements for period ended June ...
Cached Medicine Technology:Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid 2Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid 3Solos Endoscopy to Reduce Debt by Over $620,000 2
(Date:7/28/2015)... , ... July 28, 2015 , ... ... SmileCareClub Invisible Aligner System to its online product offerings, giving its ... a teledentistry model and cloud-based technology, SmileCareClub allows patients to get quality, remote ...
(Date:7/28/2015)... ... ... Women fear developing Alzheimer's disease more than having a heart attack or stroke ... but there is little an individual can do to arrest the progress of Alzheimer's ... reports the July 2015 Harvard Women's Health Watch . , "There are now ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... (ACS-Heart Attack, Sudden Death, or Angina), many of whom are missed by conventional ... of individuals with active yet undetected sub-clinical disease, who are at risk of ...
(Date:7/28/2015)... ... July 28, 2015 , ... For more than ... has based its selection process on the foundation of peer nominations. Physicians nominate ... in any area of medicine and in any part of the country. Physicians ...
(Date:7/28/2015)... Miami, FL (PRWEB) , ... July 28, 2015 ... ... according to a number of publications, including Runner’s World Magazine, is plantar ... remedy this constant pain. , Designed by a professional athletic trainer, the ...
Breaking Medicine News(10 mins):Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 3Health News:Zensah Releases Compression Sleeve To Relieve Ankle Pain and Plantar Fasciitis 2
... Calif., July 2 SuperGen, Inc.,(Nasdaq: SUPG ... rapid,development and commercialization of therapies for solid tumors ... Ph.D.,President and Chief Executive Officer, is scheduled to ... July 9, 2008 at the,Mandarin Oriental Hotel in ...
... Display Paintings at Grumpy,s Cafe; Works on Sale ... Shore Hospital,s Festival of the Arts, CLEVELAND, July 2 ... Home Art Program is now on display at Grumpy,s,Cafe, 2621 ... The exhibition includes several paintings from residents of Joseph,s,Home, a ...
... SXC Health Solutions Corp.,("SXC" or the "Company") ... leading provider of,technology and pharmacy benefits management ... informedRx suite of services with The University,of ... renewal include: RxCLAIM(R),for on-line adjudication services of ...
... supporting Lactation, Consultants, Midwives, Doulas, and Childbirth Educators, giving them ... and expand their, practices by connecting with the 2 million ... ... BOULDER, Colo., July 2 Breastfeeding.com, a premier,online resource with ...
... most powerful anti-inflammatory system, controlling digestion, detoxification, glucose metabolism as well ... nourish the cell membranes of neurons for unprecedented results in fighting ... improving energy, immune and brain function*. , ... Los ...
... should understand and consider the economic impact of new ... report appearing in the July/August issue of CA: ... of the American Cancer Society. The report says health ... to be aware of the relative costs and benefits ...
Cached Medicine News:Health News:SuperGen to Present at the Collins Stewart Growth Conference on July 9, 2008 2Health News:Artwork by Homeless Men on Display in Tremont Cafe 2Health News:Artwork by Homeless Men on Display in Tremont Cafe 3Health News:SXC Health Solutions announces informedRx renewal contract with The University of Michigan 2Health News:Breastfeeding.com Launches First Ever Social Network for Birth-Related Medical Professionals 2Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 2Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 3Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 4Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 5Health News:Report says clinicians should consider economic impact of new interventions 2